drugset

drugset / Trial / NCT00861445

A Trial to Investigate Safety and Efficacy of SPM927 in Painful Diabetic Neuropathy

NCT00861445 ↗

Phase 2 Completed 119 enrolled UCB Pharma

RandomizedParallel-groupTriple-blindTreatment

Summary

The primary purpose is to investigate the safety and efficacy of SPM927 in patients with Painful Diabetic Neuropathy

Timeline

Start: 2001-06
Primary completion: 2003-01
Completion: 2003-02

Publications

Results Rauck RL, Shaibani A, Biton V, Simpson J, Koch B. Lacosamide in painful diabetic peripheral neuropathy: a phase 2 double-blind placebo-controlled study. Clin J Pain. 2007 Feb;23(2):150-8. doi: 10.1097/01.ajp.0000210957.39621.b2.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Lacosamide	Other / unclassified	400 mg	—

Indications